Macquarie Group
BLCM

Macquarie Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Macquarie Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,078
Closed -$35K – 1935
2019
Q2 		$35K Buy
+2,078
New +$35K ﹤0.01% 1753